Edwards Lifesciences exec sells 619 shares in plan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp corporate vice president Daniel J. Lippis exercised and sold a small block of shares under a pre-planned program. He exercised employee stock options to acquire 619 shares of common stock at $72.68 per share, then sold 619 shares in an open-market sale at a weighted average price of $91.4002 per share.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2026, indicating they were pre-scheduled. After these trades, Lippis directly holds about 40,410.9103 shares of common stock and 5,571 employee stock options.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | $0.00 |
| Exercise | Common Stock | 619 | $72.68 | $45K |
| Sale | Common Stock | 619 | $91.4002 | $57K |
Footnotes (2)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Employee Stock Option (Right to Acquire) financial
open-market sale financial
derivative security financial
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did EW executive Daniel J. Lippis report?
Was the Edwards Lifesciences (EW) insider sale part of a 10b5-1 plan?
What stock options does the EW executive still retain after exercising 619 options?
What prices were involved in the Edwards Lifesciences (EW) insider trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.